CorQuest MedTech
ActiveSummary
CorQuest MedTech has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €552,771 and a net result of -€194,609. Equity is growing by about 29% per year across the filed financial years. Its solvency ranks better than 82% of 146 sector peers (NACE 26, financial year 2025). The computed 12-month bankruptcy probability is 1.1% (low).
Group and network
Connections & network
3 current directorsThe board mandates are listed below; here you explore them as a network.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.